Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138465718> ?p ?o ?g. }
- W2138465718 endingPage "73" @default.
- W2138465718 startingPage "69" @default.
- W2138465718 abstract "Clinical and laboratory investigations during the past four decades have resulted in numerous schedules, doses, and routes of delivery for methotrexate (MTX). It remains as an important drug for the treatment of children with acute lymphoblastic leukemia (ALL). Aminopterin (AMT) was the initial antifolate showing promise as an anticancer drug. It is more potent than MTX and also is known to be accumulated more efficiently than MTX in model systems. Because Whitehead et al. (Blood, 76: 44-49, 1990) have shown that MTX accumulation by blasts at diagnosis is of prognostic significance in children with ALL, we reasoned that if accumulation of a stoichiometric inhibitor of dihydrofolate reductase by leukemic blasts was of prognostic importance, then whether it was AMT or MTX may be relevant only with respect to the absolute dose. To compare MTX and AMT metabolism, we incubated lymphoblasts with 1 microM radiolabeled drug in vitro. MTX and AMT accumulation by ALL cells (n = 24) was 0.7 +/- 0.7 and 1.47 +/- 0.9 pmol/10(6) cells, respectively. Based on the data of Whitehead et al., this predicts pharmacological success in 59 and 84% of the MTX and AMT groups, respectively. Moreover, 5 of 10 patients considered poor risks based on MTX accumulation would be cures based on AMT uptake. Even at only 0.1 microM AMT, a concentration at which there is little accumulation of MTX, 5 of 11 patients studied would be pharmacological cures based on AMT uptake. Accumulation of AMT by blasts from 11 patients with T-cell-lineage ALL and 5 patients with acute myelogenous leukemia was also found to be twice the uptake of MTX. These data allow the suggestion that AMT, despite increased potential for toxicity, may be useful in children who are identified as poor risks with respect to MTX uptake." @default.
- W2138465718 created "2016-06-24" @default.
- W2138465718 creator A5044373932 @default.
- W2138465718 creator A5056916024 @default.
- W2138465718 creator A5058207633 @default.
- W2138465718 creator A5064290029 @default.
- W2138465718 date "1996-01-01" @default.
- W2138465718 modified "2023-09-23" @default.
- W2138465718 title "A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro." @default.
- W2138465718 cites W136022436 @default.
- W2138465718 cites W1503291557 @default.
- W2138465718 cites W1569512397 @default.
- W2138465718 cites W1580274291 @default.
- W2138465718 cites W1583266035 @default.
- W2138465718 cites W1606078358 @default.
- W2138465718 cites W1828955744 @default.
- W2138465718 cites W1853054 @default.
- W2138465718 cites W1967490229 @default.
- W2138465718 cites W1984522634 @default.
- W2138465718 cites W1987905087 @default.
- W2138465718 cites W2000027418 @default.
- W2138465718 cites W2031878808 @default.
- W2138465718 cites W2047861739 @default.
- W2138465718 cites W2056026080 @default.
- W2138465718 cites W2079608086 @default.
- W2138465718 cites W2081189233 @default.
- W2138465718 cites W2088147598 @default.
- W2138465718 cites W2093363417 @default.
- W2138465718 cites W2094028578 @default.
- W2138465718 cites W2096864094 @default.
- W2138465718 cites W2120946158 @default.
- W2138465718 cites W2134190122 @default.
- W2138465718 cites W2173315827 @default.
- W2138465718 cites W2173427809 @default.
- W2138465718 cites W2258754807 @default.
- W2138465718 cites W2328999771 @default.
- W2138465718 cites W2400059301 @default.
- W2138465718 cites W2424750721 @default.
- W2138465718 cites W2472288511 @default.
- W2138465718 cites W307794556 @default.
- W2138465718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9816092" @default.
- W2138465718 hasPublicationYear "1996" @default.
- W2138465718 type Work @default.
- W2138465718 sameAs 2138465718 @default.
- W2138465718 citedByCount "6" @default.
- W2138465718 countsByYear W21384657182015 @default.
- W2138465718 crossrefType "journal-article" @default.
- W2138465718 hasAuthorship W2138465718A5044373932 @default.
- W2138465718 hasAuthorship W2138465718A5056916024 @default.
- W2138465718 hasAuthorship W2138465718A5058207633 @default.
- W2138465718 hasAuthorship W2138465718A5064290029 @default.
- W2138465718 hasConcept C112705442 @default.
- W2138465718 hasConcept C113842279 @default.
- W2138465718 hasConcept C185592680 @default.
- W2138465718 hasConcept C202751555 @default.
- W2138465718 hasConcept C203014093 @default.
- W2138465718 hasConcept C2778397455 @default.
- W2138465718 hasConcept C2778461978 @default.
- W2138465718 hasConcept C2778685788 @default.
- W2138465718 hasConcept C2780035454 @default.
- W2138465718 hasConcept C2781059491 @default.
- W2138465718 hasConcept C2781107101 @default.
- W2138465718 hasConcept C2781320022 @default.
- W2138465718 hasConcept C2781382166 @default.
- W2138465718 hasConcept C2909962599 @default.
- W2138465718 hasConcept C54355233 @default.
- W2138465718 hasConcept C55493867 @default.
- W2138465718 hasConcept C71924100 @default.
- W2138465718 hasConcept C81885089 @default.
- W2138465718 hasConcept C86803240 @default.
- W2138465718 hasConcept C98274493 @default.
- W2138465718 hasConceptScore W2138465718C112705442 @default.
- W2138465718 hasConceptScore W2138465718C113842279 @default.
- W2138465718 hasConceptScore W2138465718C185592680 @default.
- W2138465718 hasConceptScore W2138465718C202751555 @default.
- W2138465718 hasConceptScore W2138465718C203014093 @default.
- W2138465718 hasConceptScore W2138465718C2778397455 @default.
- W2138465718 hasConceptScore W2138465718C2778461978 @default.
- W2138465718 hasConceptScore W2138465718C2778685788 @default.
- W2138465718 hasConceptScore W2138465718C2780035454 @default.
- W2138465718 hasConceptScore W2138465718C2781059491 @default.
- W2138465718 hasConceptScore W2138465718C2781107101 @default.
- W2138465718 hasConceptScore W2138465718C2781320022 @default.
- W2138465718 hasConceptScore W2138465718C2781382166 @default.
- W2138465718 hasConceptScore W2138465718C2909962599 @default.
- W2138465718 hasConceptScore W2138465718C54355233 @default.
- W2138465718 hasConceptScore W2138465718C55493867 @default.
- W2138465718 hasConceptScore W2138465718C71924100 @default.
- W2138465718 hasConceptScore W2138465718C81885089 @default.
- W2138465718 hasConceptScore W2138465718C86803240 @default.
- W2138465718 hasConceptScore W2138465718C98274493 @default.
- W2138465718 hasIssue "1" @default.
- W2138465718 hasLocation W21384657181 @default.
- W2138465718 hasOpenAccess W2138465718 @default.
- W2138465718 hasPrimaryLocation W21384657181 @default.
- W2138465718 hasRelatedWork W116308216 @default.
- W2138465718 hasRelatedWork W1494667414 @default.
- W2138465718 hasRelatedWork W1967512152 @default.